Medtronic wins CE mark for ApexCut surgical blades

Medtronic (NYSE:MDT) announced today that it received CE mark approval for its ApexCut surgical blades for ENT procedures.

The medtech giant said ApexCut represents its next generation of powered ear, nose and throat (ENT) instrumentation. It designed the technology to improve surgical efficiency and address frequent challenges in the operating room.

Medtronic said it developed the ApexCut blades in close collaboration with surgeons. Their design aims to reduce clogging and deliver smoother, more predictable performance during powered ENT procedures.

Sign up for Blog Updates